The purpose of this presentation is to discuss currently available biologic therapies for severe asthma, including a review of clinical trials for a new biologic recently approved in 2021. This presentation will highlight the different types of severe asthma, different therapy targets, and emphasize the need for ongoing research to expand therapy options for patients with severe asthma. Additionally, the presentation will address the role pharmacists and pharmacy technicians have in supporting severe asthma patients on biologic therapy.